OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Stock Position in GP-Act III Acquisition Corp. $GPAT

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its stake in shares of GP-Act III Acquisition Corp. (NASDAQ:GPAT) by 28.6% in the 4th quarter, Holdings Channel reports. The institutional investor owned 250,000 shares of the company’s stock after selling 100,000 shares during the quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in GP-Act III Acquisition were worth $2,675,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Longfellow Investment Management Co. LLC purchased a new stake in shares of GP-Act III Acquisition during the 3rd quarter worth approximately $83,000. Bank of America Corp DE purchased a new stake in shares of GP-Act III Acquisition during the 3rd quarter worth approximately $85,000. Clear Street Group Inc. purchased a new stake in shares of GP-Act III Acquisition during the 3rd quarter worth approximately $109,000. Cannon Global Investment Management LLC lifted its position in shares of GP-Act III Acquisition by 38.1% during the 4th quarter. Cannon Global Investment Management LLC now owns 14,500 shares of the company’s stock worth $155,000 after buying an additional 4,000 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC purchased a new stake in shares of GP-Act III Acquisition during the 3rd quarter worth approximately $203,000.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d)” rating on shares of GP-Act III Acquisition in a research report on Tuesday, April 21st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

GP-Act III Acquisition Trading Up 0.7%

GPAT stock opened at $10.92 on Tuesday. The company has a fifty day moving average price of $10.88 and a 200 day moving average price of $10.79. GP-Act III Acquisition Corp. has a 12 month low of $10.50 and a 12 month high of $12.00.

GP-Act III Acquisition (NASDAQ:GPAT) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.06 EPS for the quarter.

GP-Act III Acquisition Profile

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.